✦ LIBER ✦

Urinary N-Telopeptide Is a Rapid Predictor of Response to and Palliative Benefit from Bisphosphonate Therapy in Patients with Metastatic Breast Cancer

✍ Scribed by Simmons, Christine; Broom, Reuben J.; Cole, David E.C.; Dranitsaris, George; Clemons, Mark

Book ID: 122223507
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 418 KB
Volume: 4
Category: Article
ISSN: 1543-2912
DOI: 10.3816/SCT.2007.n.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measurement of urinary collagen cross-li

Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases

✍ Walls, J; Assiri, A; Howell, A; Rogers, E; Ratcliffe, W A; Eastell, R; Bundred, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views